Objective: To evaluate the effectiveness of rotavirus vaccination among young children in Belgium.
Design: Prospective case-control study.
Setting: Random sample of 39 Belgian hospitals, February 2008 to June 2010.
We have identified 2 antigens recognized by several melanoma-specific cytolytic T lymphocyte clones isolated from a melanoma patient with a clinical history of tumor regression after immunotherapy. Both antigens are presented by HLA-A2 and encoded by gene MAGE-C2, a cancer-germline gene shown previously to be silent in normal somatic tissues and expressed in 40% of melanomas and in other tumor types. One antigen corresponds to peptide ALKDVEERV(336-344), whereas the other corresponds to peptide LLFGLALIEV(191-200).
View Article and Find Full Text PDF